Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
BMC Infect Dis ; 14: 361, 2014 Jul 03.
Article in English | MEDLINE | ID: mdl-24990706

ABSTRACT

BACKGROUND: Human papillomavirus (HPV) serology is a main factor for designing vaccination programs and surveillance strategies; nevertheless, there are few reports of HPV seroprevalence in the general population, especially in Latin America. This study aimed to describe high-risk HPV serological prevalence, persistence, and association with concurrent cervical infection, in Chilean women. METHODS: 1021 women from the general population, aged 15-85 years, were studied in 2001 of whom 600 were reexamined in 2006. The assessments at both time points included cervical HPV DNA testing, HPV antibody testing, cervical cytology and a sociodemographic/behavioral questionnaire. HPV DNA and antibodies against L1 protein of types 16, 18, 31, 33, 35, 45, 52, and 58 were assessed by reverse line blot and multiplex serology, respectively. RESULTS: Seropositivity was high at both baseline (43.2%) and follow-up (50.2%) and increased with age (p < 0.001); corresponding DNA prevalences were 6.7% and 8.7%. DNA and seroprevalence were associated at baseline (p = 0.01 for any HPV). Early age at first sexual intercourse and having had two or more sexual partners were independently associated with seropositivity. Most (82.0%) initially seropositive women remained seropositive at follow-up; 21.6% of initially seronegative women seroconverted, reaching 17.5% among women older than 60 years of age. ASCUS or worse cytology was correlated with HPV DNA positivity but not with HPV seropositivity. CONCLUSION: HPV seroprevalence studies are a useful tool for learning about the dynamics of HPV infection in a community. This study contributes to understanding the natural history of HPV infection and provides a baseline assessment before the incorporation of HPV vaccination into a national program.


Subject(s)
Papillomaviridae/pathogenicity , Papillomavirus Infections/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Chile/epidemiology , DNA, Viral/analysis , Female , Humans , Middle Aged , Papillomaviridae/genetics , Papillomavirus Infections/blood , Risk Factors , Seroepidemiologic Studies , Sexual Partners , Surveys and Questionnaires , Vaginal Smears , Women's Health
2.
Virology ; 448: 356-62, 2014 Jan 05.
Article in English | MEDLINE | ID: mdl-24314666

ABSTRACT

Human papillomavirus (HPV) 33, a member of the HPV16-related alpha-9 species group, is found in approximately 5% of cervical cancers worldwide. The current study aimed to characterize the genetic diversity of HPV33 and to explore the association of HPV33 variants with the risk for cervical cancer. Taking advantage of the International Agency for Research on Cancer biobank, we sequenced the entire E6 and E7 open reading frames of 213 HPV33-positive cervical samples from 30 countries. We identified 28 HPV33 variants that formed 5 phylogenetic groups: the previously identified A1, A2, and B (sub)lineages and the novel A3 and C (sub)lineages. The A1 sublineage was strongly over-represented in cervical cases compared to controls in both Africa and Europe. In conclusion, we provide a classification system for HPV33 variants based on the sequence of E6 and E7 and suggest that the association of HPV33 with cervical cancer may differ by variant (sub)lineage.


Subject(s)
Alphapapillomavirus/genetics , Alphapapillomavirus/isolation & purification , Genetic Variation , Papillomavirus Infections/virology , Uterine Cervical Neoplasms/virology , Africa , Alphapapillomavirus/chemistry , Alphapapillomavirus/classification , Amino Acid Sequence , Asia , Base Sequence , Europe , Female , Humans , Molecular Sequence Data , Oncogene Proteins, Viral/chemistry , Oncogene Proteins, Viral/genetics , Phylogeny , Sequence Alignment , South America
3.
Cancer Epidemiol Biomarkers Prev ; 23(1): 107-16, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24130226

ABSTRACT

BACKGROUND: Maté tea is a nonalcoholic infusion widely consumed in southern South America, and may increase risk of esophageal squamous cell carcinoma (ESCC) and other cancers due to polycyclic aromatic hydrocarbons (PAH) and/or thermal injury. METHODS: We pooled two case-control studies: a 1988 to 2005 Uruguay study and a 1986 to 1992 multinational study in Argentina, Brazil, Paraguay, and Uruguay, including 1,400 cases and 3,229 controls. We computed ORs and fitted a linear excess OR (EOR) model for cumulative maté consumption in liters/day-year (LPDY). RESULTS: The adjusted OR for ESCC with 95% confidence interval (CI) by ever compared with never use of maté was 1.60 (1.2-2.2). ORs increased linearly with LPDY (test of nonlinearity; P = 0.69). The estimate of slope (EOR/LPDY) was 0.009 (0.005-0.014) and did not vary with daily intake, indicating maté intensity did not influence the strength of association. EOR/LPDY estimates for consumption at warm, hot, and very hot beverage temperatures were 0.004 (-0.002-0.013), 0.007 (0.003-0.013), and 0.016 (0.009-0.027), respectively, and differed significantly (P < 0.01). EOR/LPDY estimates were increased in younger (<65) individuals and never alcohol drinkers, but these evaluations were post hoc, and were homogeneous by sex. CONCLUSIONS: ORs for ESCC increased linearly with cumulative maté consumption and were unrelated to intensity, so greater daily consumption for shorter duration or lesser daily consumption for longer duration resulted in comparable ORs. The strength of association increased with higher maté temperatures. IMPACT: Increased understanding of cancer risks with maté consumption enhances the understanding of the public health consequences given its purported health benefits.


Subject(s)
Beverages/statistics & numerical data , Carcinoma, Squamous Cell/epidemiology , Esophageal Neoplasms/epidemiology , Ilex paraguariensis/chemistry , Adult , Aged , Aged, 80 and over , Beverages/adverse effects , Beverages/analysis , Carcinoma, Squamous Cell/etiology , Case-Control Studies , Esophageal Neoplasms/etiology , Esophageal Squamous Cell Carcinoma , Female , Humans , Male , Middle Aged , Plant Extracts/administration & dosage , Plant Extracts/adverse effects , Plant Leaves/chemistry , South America , Uruguay
4.
Infect Agent Cancer ; 6(1): 21, 2011 Nov 16.
Article in English | MEDLINE | ID: mdl-22087645

ABSTRACT

BACKGROUND: The need to review cervical cancer prevention strategies has been triggered by the availability of new prevention tools linked to human papillomavirus (HPV): vaccines and screening tests. To consider these innovations, information on HPV type distribution and natural history is necessary. This is a five-year follow-up study of gynecological high-risk (HR) HPV infection among a Chilean population-based cohort of women. FINDINGS: A population-based random sample of 969 women from Santiago, Chile aged 17 years or older was enrolled in 2001 and revisited in 2006. At both visits they answered a survey on demographics and sexual history and provided a cervical sample for HPV DNA detection (GP5+/6+ primer-mediated PCR and Reverse line blot genotyping). Follow-up was completed by 576 (59.4%) women; 45 (4.6%) refused participation; most losses to follow-up were women who were unreachable, no longer eligible or had missing samples. HR-HPV prevalence increased by 43%. Incidence was highest in women < 20 years of age (19.4%) and lowest in women > 70 (0%); it was three times higher among women HR-HPV positive versus HPV negative at baseline (25.5% and 8.3%; OR 3.8, 95% CI 1.8-8.0). Type-specific persistence was 35.3%; it increased with age, from 0% in women < 30 years of age to 100% in women > 70. An enrollment Pap result ASCUS or worse was the only risk factor for being HR-HPV positive at both visits. CONCLUSIONS: HR-HPV prevalence increased in the study population. All HR-HPV infections in women < 30 years old cleared, supporting the current recommendation of HR-HPV screening for women > 30 years.

5.
J Infect Dis ; 204(3): 385-90, 2011 Aug 01.
Article in English | MEDLINE | ID: mdl-21742837

ABSTRACT

OBJECTIVE: To evaluate clustering patterns of prevalent infection with multiple human papillomavirus (HPV) types in 8365 nonhysterectomized women from the Guanacaste Study of HPV Natural History. METHODS: HPV testing was performed on cervical cells by MY09/M11 L1 degenerate consensus primer polymerase chain reaction method, with dot-blot hybridization for genotyping. Logistic regression was used to model type-specific HPV positivity, adjusted for age, lifetime number of sexual partners, and specific HPV type prevalence. Woman-level random effects were added to represent unobservable risk factors common to all HPV types. RESULTS: The observed-to-expected ratio for infections with 2 types was 1.16 (95% credible interval: 1.11-1.21) and for ≥3 types was 1.04 (95% credible interval: .96-1.13). The tendency of HPV types to cluster increased significantly with the genetic similarity of L1 regions. P value < .01 was observed for 2 HPV pairs: HPV-62 and -81 were found together more, while HPV-51 and -71 were found together less often than expected. CONCLUSIONS: We found a small degree of aggregation between any HPV types and lack of clustering between specific carcinogenic types. Our data indirectly provide reassurance on lack of misclassification for the large majority of HPV types in multiple infections detected by the MY09/11 method and genotyped using dot-blot hybridization.


Subject(s)
Papillomavirus Infections/epidemiology , Adult , Aged , Cluster Analysis , Costa Rica/epidemiology , Female , Genotype , Humans , Middle Aged , Papillomaviridae/classification , Papillomavirus Infections/virology
6.
J Infect Dis ; 199(10): 1449-56, 2009 May 15.
Article in English | MEDLINE | ID: mdl-19351262

ABSTRACT

BACKGROUND: The aim of the present study was to estimate the prevalence of Kaposi sarcoma-associated herpesvirus (KSHV) in the female general population, to define geographic variation in and heterosexual transmission of the virus. METHODS: The study included 10,963 women from 9 countries for whom information on sociodemographic characteristics and reproductive, sexual, and smoking behaviors were available. Antibodies against KSHV that encoded lytic antigen K8.1 and latent antigen ORF73 were determined. RESULTS: The range of prevalence of KSHV (defined as detection of any antigen) was 3.81%-46.02%, with significant geographic variation noted. In Nigeria, the prevalence was 46.02%; in Colombia, 13.32%; in Costa Rica, 9.81%; in Argentina, 6.40%; in Ho Chi Minh City, Vietnam, 15.50%; in Hanoi, Vietnam, 11.26%; in Songkla, Thailand, 10%; in Lampang, Thailand, 8.63%; in Korea, 4.93%; and in Spain, 3.65%. The prevalence of KSHV slightly increased with increasing age among subjects in geographic areas where the prevalence of KSHV was high, such as Nigeria and Colombia, and it significantly decreased with increases in the educational level attained by subjects in those areas. KSHV was not statistically associated with age at first sexual intercourse, number of sex partners, number of children, patterns of oral contraceptive use, presence of cervical human papillomavirus DNA, or smoking status. CONCLUSIONS: The study provides comparable estimates of KSHV prevalence in diverse cultural settings across 4 continents and provides evidence that sexual transmission of KSHV is not a major source of infection in the general population.


Subject(s)
Glycoproteins/genetics , Sarcoma, Kaposi/genetics , Viral Proteins/genetics , Adult , Antigens, Viral/genetics , Colombia/epidemiology , Cross-Cultural Comparison , Female , Glycoproteins/isolation & purification , Herpesviridae Infections/epidemiology , Herpesviridae Infections/genetics , Herpesviridae Infections/transmission , Herpesvirus 8, Human , Humans , Middle Aged , Nigeria/epidemiology , Odds Ratio , Prevalence , Risk Factors , Sarcoma, Kaposi/epidemiology , Sexual Behavior , Thailand/epidemiology , Viral Proteins/isolation & purification
7.
J Med Virol ; 80(7): 1202-10, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18461622

ABSTRACT

Kaposi's sarcoma-associated herpesvirus (KSHV) is endemic in the Amazon and rare in southern regions of Brazil. However, geographical distribution and epidemiological correlates of infection in this large country are still poorly defined. To estimate the seroprevalence of, and risk factors for, KSHV infection in Brazil, a multi-center study was conducted among 3,493 first-time voluntary unpaid blood donors from Salvador, Sao Paulo and Manaus. Antibodies against KSHV were detected using a whole-virus ELISA validated prior to the serosurvey. Antibodies against the latency-associated nuclear antigen (LANA) were detected by immuno-fluorescence assay (IFA) among ELISA-positive sera and a random sample of ELISA-negative sera. Overall, seroprevalence of KSHV by whole-virus ELISA was 21.7% (95% confidence interval (CI): 20-23.4%) in men and 31.7% (95% CI: 29-34.3%) in women (P<0.0001). KSHV antibodies were detected by IFA-LANA in 3% (95% CI: 2-4.3%) of 867 ELISA-positive samples and in none of 365 randomly selected ELISA-negative samples. In multivariate analysis, KSHV seroprevalence by whole-virus ELISA was independently associated with female sex (odds ratio [OR]=1.6, 95% CI: 1.4-1.9); residence in the Amazon (OR=1.4, 95% CI: 1.2-1.8; compared to Salvador); Caucasian ethnicity (OR=1.3, 95% CI: 1.1-1.6) and herpes simplex virus type 2 (HSV-2) infection (OR=1.3, 95% CI: 1.1-1.6). KSHV seroprevalence did not significantly increase with age, nor was it associated with self-reported sexual behavior. KSHV seroprevalence is high among Brazilian blood donors, particularly from the Amazon region. This study supports the co-existence of sexual and non-sexual routes of KSHV transmission in this population.


Subject(s)
Blood Donors , Herpesvirus 8, Human/isolation & purification , Sarcoma, Kaposi/epidemiology , Adolescent , Adult , Brazil/epidemiology , Female , Humans , Male , Middle Aged , Prevalence , Risk Factors , Sarcoma, Kaposi/etiology , Sarcoma, Kaposi/virology
8.
Infect Agent Cancer ; 3: 5, 2008 Mar 14.
Article in English | MEDLINE | ID: mdl-18341690

ABSTRACT

OBJECTIVES: To evaluate the prevalence of human papillomavirus (HPV) types, and risk factors for HPV positivity across cervix, vagina and anus, we conducted a study among 138 women with human immunodeficiency virus (HIV). GOAL: Compare the prevalence of different HPV types and the risk factors for HPV positivity in three sites. RESULTS: The most frequently detected HPV types in all sites were, in decreasing order, HPV16, 53, 18, 61 and 81. Agreement between the cervix and vagina was good (kappa 0.60 - 0.80) for HPV16 and 53 and excellent (Kappa > 0.80) for HPV18 and 61. HPV positivity was inversely associated with age for all combinations including the anal site. CONCLUSION: In HIV positive women, HPV18 is the most spread HPV type found in combinations of anal and genital sites. The relationship of anal to genital infection has implications for the development of anal malignancies. Thus, the efficacy of the current HPV vaccine may be considered not only for the cervix, but also for prevention of HPV18 anal infection among immunossuppressed individuals.

9.
Eur J Cancer Prev ; 17(2): 178-83, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18287876

ABSTRACT

Chronic inflammation induced by Helicobacter pylori is a key process in gastric carcinogenesis. We hypothesized that genetic polymorphisms in important mediators of H. pylori-induced inflammation may influence the risk of developing various grades of precancerous lesions. We studied the associations between single nucleotide polymorphisms (SNPs) in cyclooxygenase 1 and 2 (PTGS1 and PTGS2), inducible nitric oxide synthase (NOS2A), interferon gamma (IFNG) and its receptor (IFNGR1), and risk of gastric precancerous lesions in a Venezuelan population characterized by high rates of H. pylori infection. We found no association of precancerous lesions with SNPs in PTGS1 and in IFNG. A nonsynonymous SNP of NOS2A (Ser608Leu) and an SNP located in the promoter of IFNGR1 (C-56T) were associated with higher risk of atrophic gastritis [odds ratio (OR)=1.37, 95% confidence interval (CI)=1.01-1.86, and OR=1.49, 95% CI=1.01-2.19, respectively]. Two SNPs of PTGS2 were associated with risk of dysplasia (OR=1.60, 95% CI=1.01-2.54, and OR=0.66, 95% CI=0.43-0.99). We conclude that genetic variability in the genes we studied does not play a major role in the early stages of gastric carcinogenesis.


Subject(s)
Helicobacter Infections/complications , Stomach Neoplasms/genetics , Stomach Neoplasms/microbiology , Adult , Aged , Cyclooxygenase 1/genetics , Cyclooxygenase 2/genetics , Female , Helicobacter Infections/epidemiology , Helicobacter pylori , Humans , Inflammation , Interferon-gamma/genetics , Male , Middle Aged , Nitric Oxide Synthase Type II/genetics , Polymorphism, Single Nucleotide , Precancerous Conditions/genetics , Receptors, Interferon/genetics , Risk Factors , Stomach Neoplasms/epidemiology , Venezuela/epidemiology , Interferon gamma Receptor
10.
J Med Virol ; 80(1): 53-7, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18041005

ABSTRACT

Little data are available on the seroprevalence of, and risk factors for hepatitis B and C viruses (HBV and HCV) infection in Latin American countries. A multi-center serosurvey was conducted among 3,598 first-time blood donors (65% men) from Sao Paulo, Salvador and Manaus in Brazil. The gender-specific seroprevalences of antibodies against hepatitis B core antigen (anti-HBc) and of the hepatitis B surface antigen (HBsAg) in anti-HBc-positive sera were measured, and risk factors analyzed by gender. The gender-specific seroprevalences of antibodies against HCV (anti-HCV) were measured, but risk factors for HCV were not determined. Anti-HBc and HBsAg seroprevalences were not significantly different in men [101/2,341 (4.31%) and 4/2,229 (0.18%), respectively] and women [65/1,237 (5.25%) and 8/1,169 (0.68%), respectively], whereas the seroprevalence of anti-HCV was higher in women (12/1,238 [0.97%] vs. 9/2,353 [0.38%]; odds ratio [OR] = 2.49; 95% confidence interval [CI]: 1.0-6.0). No significant difference for HBV infection was found across the three study sites or by ethnic group. The seroprevalence of anti-HBc increased with age, but decreased with education level in both genders. Lifetime number of sexual partners was associated with anti-HBc prevalence among men (OR = 1.95; 95% CI: 1.2-3.1), but not women. The seroprevalence of HBV and HCV was low among Brazilian blood donors, and exposure increased with age in both genders.


Subject(s)
Blood Donors , Hepatitis B Antibodies/analysis , Hepatitis B/epidemiology , Hepatitis C Antibodies/analysis , Hepatitis C/epidemiology , Seroepidemiologic Studies , Brazil/epidemiology , DNA, Viral , Female , Hepatitis B/blood , Hepatitis B/immunology , Hepatitis B Antibodies/blood , Hepatitis C/blood , Hepatitis C/immunology , Hepatitis C Antibodies/blood , Humans , Male , Population Surveillance , Sex Distribution , Sexual Partners
11.
Sex Transm Dis ; 34(8): 563-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17417132

ABSTRACT

OBJECTIVES: Better information on the prevalence of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infection is needed in many world areas. STUDY DESIGN: Cross-sectional study of population-based samples of nonpregnant women aged 15 to 44 years in Nigeria, Colombia, Argentina, Vietnam (2 areas), China, Thailand (2 areas), Korea, and Spain. 5,328 consenting women aged 15 to 44 years participated. Exfoliated cervical cells were collected and testing for CT and NG and human papillomavirus (HPV) was done using PCR-based assays. RESULTS: Age-standardized CT prevalence ranged between 0.2% (95% confidence interval, CI: 0.0-0.7%) in Spain and 5.6% (95% CI: 3.4-7.8%) in Nigeria. NG ranged between 0% (with broad CIs) in several areas and 2.6% (95% CI: 1.0-4.2%) in Nigeria. Prevalence of CT in all areas combined was greater in women aged 15 to 24 (4.5; 95% CI: 3.4-5.8%) than 25 to 44 (2.6; 95% CI: 2.1-3.1%), whereas NG prevalence was similar in the 2 age groups (0.3%). The only significant risk factors were NG infection (for CT), CT infection (for NG) and infection with high-risk HPV types (for both). CONCLUSIONS: The prevalence of CT and, most notably, NG was relatively low in a variety of countries. Our findings, however, do not apply to subsets of high-risk women who are likely to be underrepresented in our population-based samples.


Subject(s)
Chlamydia Infections/epidemiology , Chlamydia trachomatis , Gonorrhea/epidemiology , Uterine Cervical Diseases/epidemiology , Adolescent , Adult , Asia/epidemiology , Chlamydia Infections/etiology , Chlamydia Infections/prevention & control , Colombia/epidemiology , Cross-Sectional Studies , Female , Gonorrhea/etiology , Gonorrhea/prevention & control , Humans , Neisseria gonorrhoeae , Nigeria/epidemiology , Prevalence , Risk Factors , Spain/epidemiology , Uterine Cervical Diseases/etiology , Uterine Cervical Diseases/prevention & control
12.
J Natl Cancer Inst ; 99(2): 137-46, 2007 Jan 17.
Article in English | MEDLINE | ID: mdl-17227997

ABSTRACT

BACKGROUND: Gastric cancer is one of the most common malignancies worldwide. Histopathologic studies have identified a sequence of changes in the gastric mucosa that mark the slow progression from normal tissue to carcinoma. Epidemiologic evidence suggests that a diet rich in fresh fruit and vegetables could be a protective factor against this disease. This effect may be mediated through antioxidant vitamins. METHODS: A randomized, double-blind chemoprevention trial was conducted among 1980 subjects in Tachira State, Venezuela (whose population is at high risk for gastric cancer), to determine the effect of dietary supplementation with vitamin C, vitamin E, and beta-carotene on the progression and regression of precancerous gastric lesions. Subjects were randomly assigned to receive either a combination of vitamin C (750 mg/day), vitamin E (600 mg/day), and beta-carotene (18 mg/day) or placebo for 3 years. Changes in the gastric mucosa were determined by histologic diagnosis based on five biopsies taken from prespecified areas of the stomach at baseline and annually for 3 years. All biopsies were reviewed by a single expert pathologist. Progression rates (and regression rates) were calculated by comparing the first and last available gastroscopies for each subject and dividing the number of subjects whose diagnoses increased (decreased) in severity by the total follow-up time. Overall rate ratios were calculated by Poisson regression, controlling for baseline diagnosis. All statistical tests were two-sided. RESULTS: Median plasma vitamin levels were increased in the treatment group between baseline and 1 year after randomization from 0.43 micromol/L (interquartile range [IQR] = 0.26-0.69) to 2.89 micromol/L (IQR = 1.76-4.22) for beta-carotene, from 26.7 micromol/L (IQR = 23.1-31.2) to 54.9 micromol/L (IQR = 42.8-67.6) for alpha-tocopherol, and from 47.70 micromol/L (IQR = 36.9-58.5) to 61.9 micromol/L (IQR = 52.2-72.7) for vitamin C. Overall progression rates per 100 person-years were 74.3 in the placebo group and 67.8 in the group randomly assigned to vitamins. Overall regression rates were 109.4 in the placebo group and 116.5 in the group randomly assigned to vitamins. There was no statistically significant difference in progression rate (rate ratio = 0.92, 95% confidence interval [CI] = 0.74 to 1.15) or regression rate (rate ratio = 1.09, 95% CI = 0.90 to 1.33) between vitamin and placebo groups. CONCLUSION: Supplementation with antioxidant micronutrients is not an effective tool for gastric cancer control in this high-risk population. The results of this trial are consistent with previous findings on the lack of effect of nutritional supplementation on precancerous gastric lesions.


Subject(s)
Antioxidants/administration & dosage , Gastric Mucosa/drug effects , Gastric Mucosa/pathology , Precancerous Conditions/prevention & control , Stomach Neoplasms/prevention & control , Vitamins/administration & dosage , Adult , Aged , Antioxidants/metabolism , Ascorbic Acid/administration & dosage , Cell Transformation, Neoplastic/drug effects , Cell Transformation, Neoplastic/pathology , Disease Progression , Double-Blind Method , Female , Gastroscopy , Helicobacter Infections/complications , Helicobacter pylori , Humans , Logistic Models , Male , Middle Aged , Patient Selection , Precancerous Conditions/blood , Precancerous Conditions/diagnosis , Precancerous Conditions/microbiology , Risk Assessment , Sample Size , Smoking/adverse effects , Stomach Neoplasms/blood , Stomach Neoplasms/diagnosis , Stomach Neoplasms/microbiology , Treatment Failure , Venezuela , Vitamin E/administration & dosage , Vitamins/blood , beta Carotene/administration & dosage
13.
Dig Dis Sci ; 52(1): 254-61, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17171451

ABSTRACT

As Helicobacter pylori (HP) is a Gram-negative bacterium, we investigated the associations between several functional polymorphisms in genes involved in lipopolysaccharide (LPS) signaling and the prevalence of various stages of gastric premalignant lesions in a Venezuelan population. The two NOD2 polymorphisms, del3020insC and Gly908Arg, were too infrequent to study their associations with gastric lesions. The risk of intestinal metaplasia (IM) was significantly increased among subjects with the CD14 T-260 allele compared to those without this allele. A similar, but nonsignificant increase in risk for dysplasia was observed among homozygotes of this allele. There was no association between TLR4 Asp299Gly polymorphism and any type of lesions, except for a slight nonsignificant increase in risk of IM associated with the AA genotype among subjects with a higher histological HP score. These results suggest that genetic polymorphisms in HP LPS signaling may be implicated in the development of intermediate stages of gastric premalignant lesions.


Subject(s)
Helicobacter pylori/genetics , Lipopolysaccharide Receptors/genetics , Lipopolysaccharides/metabolism , Nod2 Signaling Adaptor Protein/metabolism , Peptidoglycan/metabolism , Polymorphism, Genetic , Precancerous Conditions/genetics , Stomach Neoplasms/genetics , Toll-Like Receptor 4/genetics , Adult , Female , Gastroscopy , Genotype , Helicobacter Infections , Humans , Male , Middle Aged , Stomach Neoplasms/epidemiology , Stomach Neoplasms/microbiology , Venezuela/epidemiology
14.
Cancer Causes Control ; 17(9): 1183-91, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17006724

ABSTRACT

OBJECTIVES: The aim of the study was to assess the effects of genetic polymorphisms in anti-inflammatory mediators, i.e., IL10, IL4 and IL4R on the prevalence of gastric precancerous lesions and their interactions with other environmental factors. METHODS: The study population consisted of 2,033 Venezuelan subjects known to have extremely high Helicobacter Pylori (HP) infection rates. The odds ratios (OR) and 95% confidence intervals (CI) associated with these polymorphisms were estimated by multinominal logistic regression models for gastric precursor lesions. RESULTS: We found a 60% increase in risk of intestinal metaplasia (IM) and dysplasia combined (OR 1.62, 95% CI: 1.10-2.38) among the carriers of the IL10-1082 low activity allele. This increased risk was more pronounced for dysplasia than for IM. On the other hand, homozygotes with the low activity allele of the A398G polymorphism in the IL4R gene had a modest increase in risk of atrophic gastritis (OR = 1.52, 95% CI: 1.05-2.21), compared with homozygotes of the high activity allele. There were no statistically significant synergetic interactions between these polymorphisms and environmental risk factors (low fruit intake, high starchy vegetable intake and cigarette smoking) for these lesions. CONCLUSION: While the results of the present study suggest roles of genetic variability in these anti-inflammatory mediators in different stages of gastric carcinogenesis, there is high likelihood that they were chance findings due to multiple comparisons.


Subject(s)
Cytokines/genetics , Inflammation Mediators , Polymorphism, Single Nucleotide , Precancerous Conditions/genetics , Signal Transduction/genetics , Stomach Neoplasms/genetics , Adult , Aged , Cytokines/metabolism , Female , Gastritis/epidemiology , Gastritis/genetics , Gastritis/microbiology , Gene Frequency , Genetic Predisposition to Disease , Genotype , Helicobacter Infections/complications , Helicobacter Infections/epidemiology , Helicobacter Infections/microbiology , Helicobacter pylori/genetics , Humans , Interleukin-10/genetics , Interleukin-4/genetics , Intestines/microbiology , Intestines/pathology , Logistic Models , Male , Metaplasia , Middle Aged , Precancerous Conditions/epidemiology , Precancerous Conditions/microbiology , Prevalence , Receptors, Interleukin-4/genetics , Risk Assessment , Risk Factors , Stomach Neoplasms/epidemiology , Stomach Neoplasms/microbiology , Venezuela/epidemiology
15.
Int J Cancer ; 119(7): 1666-71, 2006 Oct 01.
Article in English | MEDLINE | ID: mdl-16671087

ABSTRACT

Helicobacter pylori (HP) infection affects over 50% of the world's population. The prevalence is over 90% in populations at high risk for gastric cancer, but clinical outcomes of the infection are highly variable and thus host genetic factors have been suggested to play a role in its outcomes in addition to bacterial factors. In this study, we examined the effects of common functional genetic polymorphisms of several proinflammatory cytokines known to be overexpressed in HP-infected gastric mucosa on the risk of various stages of gastric premalignant lesions. The odds ratios (ORs) and 95% confidence intervals (CI) for atrophic gastritis, intestinal metaplasia and dysplasia were estimated by multinominal logistic regression analysis among 2,033 Venezuelan subjects. There was a significant effect of IL8 -251A allele on the prevalence of dysplasia (p = 0.021). The OR associated with the A-allele was 1.34 (95% CI: 0.82-2.18) for heterozygotes and 2.00 (95% CI: 1.13-3.56) for homozygotes, compared with the TT genotype. Furthermore, there was a statistically significant interaction between the number of A-alleles and HP cag A genotype (p = 0.009), suggesting that the A-allele increased the risk of dysplasia only when cag A was present. The OR for the AA compared with TT genotype was 3.22 (95% CI: 1.60-6.52) in this group. There were no associations with other proinflammatory cytokines studied, i.e., IL1 beta, IL6, monocyte chemoattractant protein 1 (MCP1) and TNF alpha, or with other stages of premalignant lesions. The present study provides important evidence suggesting host-bacterial interactions in the development of gastric precancerous lesions.


Subject(s)
Helicobacter Infections/epidemiology , Helicobacter Infections/pathology , Helicobacter pylori/genetics , Precancerous Conditions/epidemiology , Precancerous Conditions/genetics , Stomach Neoplasms/epidemiology , Stomach Neoplasms/genetics , Alleles , Genotype , Helicobacter Infections/genetics , Helicobacter Infections/microbiology , Helicobacter pylori/physiology , Polymorphism, Genetic/genetics , Precancerous Conditions/microbiology , Precancerous Conditions/pathology , Risk Factors , Stomach Neoplasms/diagnosis , Stomach Neoplasms/microbiology , Venezuela/epidemiology
16.
Int J Cancer ; 119(8): 1934-9, 2006 Oct 15.
Article in English | MEDLINE | ID: mdl-16708372

ABSTRACT

Large studies of genital human papillomavirus (HPV) infection in men are few and mainly include high-risk groups. We interviewed 779 men who requested a vasectomy in 27 public clinics in 14 states of Mexico. Exfoliated cells were obtained from the scrotum, the shaft of the penis, the top of the penis including the coronal sulcus, the glans and the opening of the meatus. HPV testing was performed using biotinylated L1 consensus primers and reverse line blot. Unconditional logistic regression was used to estimate odds ratios (ORs) of being HPV-positive and corresponding 95% confidence intervals (CIs). The prevalence of any type of HPV was 8.7%. HPV positivity was highest among men below age 25 (13.6%), and lowest among men aged 40 years or older (6.0%). The most commonly found HPV types were, in decreasing order, HPV59, 51, 6, 16 and 58. Lifetime number of sexual partners was associated with HPV positivity (OR for > or = 4 vs. 1 partner = 3.7, 95% CI: 2.0-6.8), mainly on account of the strong association with number of occasional and sex-worker partners. Condom use with both regular (OR = 0.4, 95% CI: 0.1-1.0) and sex-worker (OR = 0.1, 95% CI: 0.0-0.3) partners and circumcision (OR = 0.2, 95% CI: 0.1-0.4) were inversely associated with HPV positivity. HPV prevalence in Mexican men was similar to the prevalence found in Mexican women of the same age groups. The association between HPV positivity and lifetime number of sexual partners in the present low-risk male population is one of the strongest ever reported in studies in men. Condom use and circumcision were associated with a strong reduction in HPV prevalence.


Subject(s)
Papillomaviridae/pathogenicity , Papillomavirus Infections/epidemiology , Papillomavirus Infections/virology , Vasectomy , Adult , DNA, Viral/genetics , Female , Hospitals , Humans , Male , Mexico/epidemiology , Papillomavirus Infections/genetics , Risk Factors , Time Factors
18.
Am J Epidemiol ; 162(9): 907-16, 2005 Nov 01.
Article in English | MEDLINE | ID: mdl-16177149

ABSTRACT

Male circumcision has been shown to reduce the risk of acquiring and transmitting a number of venereal infections. However, little is known about the association between male circumcision and the risk of Chlamydia trachomatis infection in the female partner. The authors pooled data on 305 adult couples enrolled as controls in one of five case-control studies of invasive cervical cancer conducted in Thailand, the Philippines, Brazil, Colombia, and Spain between 1985 and 1997. Women provided blood samples for C. trachomatis and Chlamydia pneumoniae antibody detection; a type-specific microfluorescence assay was used. Multivariate odds ratios were computed for the association between male circumcision status and chlamydial seropositivity in women. Compared with women with uncircumcised partners, those with circumcised partners had a 5.6-fold reduced risk of testing seropositive for C. trachomatis (82% reduction; odds ratio = 0.18, 95% confidence interval: 0.05, 0.58). The inverse association was also observed after restricting the analysis to monogamous women and their only male partners (odds ratio = 0.21, 95% confidence interval: 0.06, 0.72). In contrast, seropositivity to C. pneumoniae, a non-sexually-transmitted infection, was not significantly related to circumcision status of the male partner. These findings suggest that male circumcision could reduce the risk of C. trachomatis infection in female sexual partners.


Subject(s)
Chlamydia Infections/epidemiology , Chlamydia trachomatis , Circumcision, Male , Sexual Partners , Adult , Brazil/epidemiology , Colombia/epidemiology , Female , Humans , Male , Middle Aged , Philippines/epidemiology , Risk Assessment , Seroepidemiologic Studies , Sexual Behavior , Spain/epidemiology , Thailand/epidemiology
19.
Cancer Epidemiol Biomarkers Prev ; 14(7): 1710-6, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16030106

ABSTRACT

BACKGROUND: Human papillomavirus (HPV) infection is sexually transmitted, but the nature of the infection in males is poorly understood. We sought to identify determinants of HPV infection, acquisition, and persistence in 1,030 healthy military men in Mexico. METHODS: From July 2000 to July 2003, trained interviewers administered a questionnaire, conducted a genital examination, and collected samples. The presence of multiple HPV types in genital cells from the urethra, urethral meatus, scrotum, penile shaft, and coronal sulcus was evaluated. At baseline 1,030 participants and after 1-year follow-up 336 individuals were sampled using a highly sensitive DNA reverse blot strip assay. RESULTS: HPV prevalence was 44.6%; infection with high-risk types was observed in 34.8% participants and 51.1% were multiply infected. After 1-year follow-up, 165 men remained free of HPV, 68 cleared their infection, 45 acquired one, and 37 remained infected with the same HPV type. The period prevalence was 50.9%, the incidence rate was 17.9/1,000 men-months [95% confidence interval (95% CI), 13.0-23.9], clearance was 54%, and persistence was 29.4%. At baseline, the number of partners before age 20 years, a history of a sexually transmitted disease, and the presence of condilomas significantly increased the association with HPV infection. Having anal intercourse with males was associated with the risk of acquiring a HPV infection (odds ratio, 5.2; 95% CI, 1.2-23). The odds ratio for persistent infection was 0.10 (95% CI, 0-0.87) in men who reported being circumcised compared with those who did not. CONCLUSIONS: High-risk sexual behavior increases the risk of HPV infection in males, whereas circumcision may lower the risk of persistence.


Subject(s)
Military Personnel , Papillomaviridae/isolation & purification , Papillomavirus Infections/epidemiology , Adult , Humans , Male , Mexico/epidemiology , Papillomavirus Infections/transmission , Prevalence , Sexual Behavior , Surveys and Questionnaires
20.
J Infect Dis ; 191(6): 907-16, 2005 Mar 15.
Article in English | MEDLINE | ID: mdl-15717266

ABSTRACT

The natural course of Chlamydia trachomatis infection and its risk factors were studied in Colombian women with normal cytological results, during a 5-year period. Eighty-two women who were found to be positive for C. trachomatis at the start of the study were studied at 6-month intervals. At each visit, a cervical scrape sample was obtained for detection of C. trachomatis by use of C. trachomatis endogenous-plasmid polymerase chain reaction (PCR)-enzyme immunoassay and VD2-PCR-reverse line blot assay. Of the women studied, 67% had a single-serovar infection, 10% had a mixed-serovar infection, and 23% had an infection with an unidentified type. An inversed rate of clearance of C. trachomatis infection was observed with oral contraceptive use (hazard ratio [HR], 1.7 [95% confidence interval {CI}, 1.1-2.7]) and first sexual intercourse at >/=20 years of age (HR, 4.3 [95% CI, 2.3-8.0]). Serovars of group B (B, D, and E) and C (H, I, J, and K) had a decreased rate of clearance (rate ratio, 0.4 [95% CI, 0.1-0.9]), compared with that for serovars of the intermediate group (F and G). At 4 years of follow-up, 94% of the women had cleared their infections.


Subject(s)
Chlamydia Infections/physiopathology , Chlamydia trachomatis/classification , Chlamydia trachomatis/isolation & purification , Adolescent , Adult , Cervix Uteri/microbiology , Chlamydia Infections/immunology , Chlamydia Infections/microbiology , Chlamydia trachomatis/genetics , Colombia , Female , Follow-Up Studies , Humans , Immunoenzyme Techniques , Plasmids/genetics , Polymerase Chain Reaction/methods , Risk Factors , Serotyping , Specimen Handling/methods
SELECTION OF CITATIONS
SEARCH DETAIL